SCHEMBL200210

SCHEMBL200210

CCCCOC(=O)O[C@@]1(NC(=O)c2cnc3[nH]cnc3c2)CCOC1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.33
SLC6A5 Q9Y345 2/20 0.33
LMNA P02545 3/20 0.33
P2RX3 P56373 1/20 0.33
ALDH1A1 P00352 3/20 0.32
RAB9A P51151 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTT P42858 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31
XDH P47989 1/20 0.31
HPGDS O60760 1/20 0.31
SPHK1 Q9NYA1 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14856552 0.80 HTR2A (0.33) HTR2ASLC6A5LMNAP2RX3ALDH1A1
SCHEMBL2808309 0.72 CYP4F2 (0.38) HTTCYP4F2CYP4A11HPGDS
SCHEMBL198340 0.65 GPR132 (0.36) LMNAALDH1A1RAB9ASMN1; SMN2MAPT
SCHEMBL10065476 0.64 CYP4F2 (0.36) HTR2ASLC6A5LMNAP2RX3ALDH1A1
SCHEMBL184727 0.63 HDAC3 (0.39) DGAT2
SCHEMBL10070601 0.63 SPHK1 (0.37) HTR2ASLC6A5LMNAP2RX3ALDH1A1
SCHEMBL2808139 0.62 DDB1 (0.40) CYP4F2CYP4A11
SCHEMBL185116 0.61 LMNA (0.40) LMNAALDH1A1RAB9ASMN1; SMN2CYP1A2
SCHEMBL14856657 0.61 KDM4E (0.45) ALDH1A1SMN1; SMN2CYP4F2CYP4A11XDH
SCHEMBL185855 0.61 KDM4E (0.41) LMNAALDH1A1XDHDGAT2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed